Paraneoplastic hypertrophic osteopathy in 30 dogs

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Paraneoplastic hypertrophic osteopathy (pHO) is known to occur in both canine and human cancer patients. While the pathology of pHO is well-described in the dog, very little information exists regarding the true clinical presentation of dogs affected with pHO. The primary objective of this study was to provide a more comprehensive clinical picture of pHO. To this end, we retrospectively identified 30 dogs and recorded data regarding presenting complaints and physical examination (PE) findings on the date of pHO diagnosis. As a secondary objective, any blood test results were also collected from the computerized records. The most common clinical signs included leg swelling, ocular discharge and/or episcleral injection, lameness, and lethargy. The most common haematological and serum biochemical abnormalities included anaemia, neutrophilia and elevated alkaline phosphatase. In addition to presenting a more detailed clinical description of pHO in the dog, these data support the previously described haematological, serum biochemical and PE abnormalities published in individual case reports.

Original languageEnglish (US)
JournalVeterinary and Comparative Oncology
StateAccepted/In press - 2013


  • Comparative oncology
  • Imaging
  • Metastasis
  • Pathology
  • Small animal

ASJC Scopus subject areas

  • veterinary(all)


Dive into the research topics of 'Paraneoplastic hypertrophic osteopathy in 30 dogs'. Together they form a unique fingerprint.

Cite this